News|Articles|September 23, 2024
Nitrosamines, Meeting Regulatory Requirements
Author(s)Phenomenex, Inc.
The necessity to analyse drug products for nitrosamines and NDSRIs (Nitrosamine Drug Substance Related Impurities) is well documented. In this document we provide an overview of 7 of our most recent applications in this area, together with links to the relevant technical notes.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
3
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5